Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.16 | 11.07 |
PEG Ratio (TTM) | 0.00 | -0.16 |
P/S Ratio (TTM) | 2.90 | 4.96 |
P/B Ratio (TTM) | -0.31 | 16.95 |
P/FCF Ratio (TTM) | -0.46 | 20.48 |
Price to 5YR AVG Earnings Ratio | -0.08 | 25.48 |
Price to 5YR AVG FCF Ratio | -0.49 | 12.76 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -78.54% | 6.07% |
ROE (TTM) | 870.27% | 53.24% |
Net Profit Margin (TTM) | -1,735.21% | -157.14% |
ROIC 5YR AVG | -146.44% | 5.89% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -15.36% | -57.58% | -42.73% |
Revenue | 4,327.94% | 214.99% | 150.93% |
Net Income | -25.95% | -85.38% | -69.03% |
Cash Flow | 11.42% | -84.32% | -46.22% |
Health (7%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.74 | 1.47 |
Quick Ratio (TTM) | 0.44 | 1.24 |
D/E Ratio (TTM) | -1.27 | 1.50 |
Interest Coverage (TTM) | -4.99 | 10.55 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | N/A | 4.75 |
LTL to 5YR AVG FCF | -2.08 | 1.39 |
Shares Outstanding Growth 5YR AVG | 17.77% | -0.10% |